TNF Pharmaceuticals, Inc. (TNFA)

NASDAQ: TNFA · Real-Time Price · USD

0.2200

+0.0280 (14.58%)

At close: Apr 25, 2025, 4:00 PM

0.2250

+0.0050 (2.27%)

Pre-market: Apr 28, 2025, 6:45 AM EDT

TNF Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Selling, General & Admin	4.16	5.44	5.52	6.42	2.95	Upgrade
Research & Development	3.44	7.87	9.07	6.75	2.47	Upgrade
Operating Expenses	8.66	16.36	15.28	28.2	8.3	Upgrade
Operating Income	-8.66	-16.36	-15.28	-28.2	-8.3	Upgrade
Interest Expense	-	-	-	-0.61	-1.19	Upgrade
Interest & Investment Income	0.35	0.46	0.08	0.01	0	Upgrade
Other Non Operating Income (Expenses)	-15.15	12.08	-	-	-	Upgrade
EBT Excluding Unusual Items	-23.46	-3.82	-15.2	-28.8	-9.49	Upgrade
Gain (Loss) on Sale of Investments	0	0	-0	-0	-	Upgrade
Other Unusual Items	0.1	-0.18	0	-1.09	-	Upgrade
Pretax Income	-23.36	-4	-15.2	-29.89	-9.49	Upgrade
Net Income	-23.36	-4	-15.2	-29.89	-9.49	Upgrade
Preferred Dividends & Other Adjustments	3.8	4.22	-	-	-	Upgrade
Net Income to Common	-27.16	-8.22	-15.2	-29.89	-9.49	Upgrade
Shares Outstanding (Basic)	2	2	1	1	1	Upgrade
Shares Outstanding (Diluted)	2	2	1	1	1	Upgrade
Shares Change (YoY)	57.99%	19.18%	10.88%	24.22%	-25.94%	Upgrade
EPS (Basic)	-11.15	-5.33	-11.74	-25.61	-10.10	Upgrade
EPS (Diluted)	-11.15	-5.33	-11.74	-25.61	-10.10	Upgrade
EBITDA	-	-	-	-28.18	-8.28	Upgrade
D&A For EBITDA	-	-	-	0.02	0.02	Upgrade
EBIT	-8.66	-16.36	-15.28	-28.2	-8.3	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q